Human challenge trials to assess the efficacy of currently approved COVID-19 vaccines against SARS-CoV-2 variants

Emerg Microbes Infect. 2021 Dec;10(1):439-441. doi: 10.1080/22221751.2021.1896956.

¹ Key Laboratory of Medical Molecular Virology (MOE/MOH/CAM), School of Basic Medical Sciences, Shanghai Institute of Infectious Diseases and Biosecurity, Fudan University, Shanghai, People's Republic of China.
² State Key Laboratory of Infectious Disease Prevention and Control (SKLID), National Center for AIDS/STD Control and Prevention (NCAIDS), Chinese Center for Disease Control and Prevention (China CDC), Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Beijing, People's Republic of China.

No abstract available

Publication types

Shibo Jiang and Yiming Shao were supported by grants from the National Natural Science Foundation of China [grant number 82041025 and U20A20362].